{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:49:35Z","timestamp":1762508975862,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.aace.2023.04.005","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T18:11:49Z","timestamp":1681409509000},"page":"104-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pancreatitis in a 57-Year-Old Female Two Weeks After Initiation of Empagliflozin"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7055-7512","authenticated-orcid":false,"given":"Alekya","family":"Poloju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Majety","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Groysman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aace.2023.04.005_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.aace.2023.04.005_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00592-018-1116-0","article-title":"SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Puckrin","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.aace.2023.04.005_bib3","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/dom.14075","article-title":"Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Liu","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.aace.2023.04.005_bib4","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000530","article-title":"Empagliflozin-associated pancreatitis: a consideration for SGLT2 inhibitors","volume":"8","author":"Dziadkowiec","year":"2021","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.aace.2023.04.005_bib5","article-title":"Empagliflozin-induced pancreatitis: a case report pattern","volume":"14","author":"Foster","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.aace.2023.04.005_bib6","article-title":"Adverse side effects: empagliflozin-related acute pancreatitis case report","volume":"12","author":"Zeidan","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.aace.2023.04.005_bib7","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.eprac.2022.10.027","article-title":"Abstract #1316800: acute pancreatitis as a rare side effect of using empagliflozin","volume":"28","author":"Alqurashe","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.aace.2023.04.005_bib8","first-page":"101","article-title":"Acute pancreatitis in the use of canagliflozin: a rare side-effect of the novel therapy for type 2 diabetes mellitus","volume":"6","author":"Srivali","year":"2015","journal-title":"J\u00a0Basic Clin Pharm"},{"key":"10.1016\/j.aace.2023.04.005_bib9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2147\/TCRM.S86641","article-title":"Canagliflozin-induced pancreatitis: a rare side effect of a new drug","volume":"11","author":"Chowdhary","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.aace.2023.04.005_bib10","doi-asserted-by":"crossref","first-page":"e496","DOI":"10.1097\/MJT.0000000000000561","article-title":"Drug-induced necrotizing pancreatitis with a focus on canagliflozin","volume":"24","author":"Patel","year":"2017","journal-title":"Am J Ther"},{"key":"10.1016\/j.aace.2023.04.005_bib11","doi-asserted-by":"crossref","first-page":"e972","DOI":"10.1097\/MJT.0000000000000135","article-title":"Canagliflozin-associated acute pancreatitis","volume":"23","author":"Verma","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.aace.2023.04.005_bib12","article-title":"Dapagliflozin-induced acute pancreatitis: a case report and review of literature","volume":"2020","author":"Sujanani","year":"2020","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/j.aace.2023.04.005_bib13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2337\/ds21-0025","article-title":"Probable dapagliflozin-associated acute pancreatitis","volume":"35","author":"Barrett","year":"2022","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.aace.2023.04.005_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1053\/j.gastro.2021.10.017","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021","volume":"162","author":"Peery","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aace.2023.04.005_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/pds.4943","article-title":"Pancreatic safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"29","author":"Tang","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.aace.2023.04.005_bib16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s11096-022-01476-7","article-title":"SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports","volume":"44","author":"Palapra","year":"2022","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.aace.2023.04.005_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.936651","article-title":"Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: an infodemiological study","volume":"9","author":"Dzaye","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.aace.2023.04.005_bib18","article-title":"Lisinopril-induced acute necrotizing pancreatitis","volume":"13","author":"Syed","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.aace.2023.04.005_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4291\/wjgp.v5.i4.405","article-title":"Contemporary review of drug-induced pancreatitis: a different perspective","volume":"5","author":"Hung","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.aace.2023.04.005_bib20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cgh.2006.11.023","article-title":"Drug-induced acute pancreatitis: an evidence-based review","volume":"5","author":"Badalov","year":"2007","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060523000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060523000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:32:28Z","timestamp":1762497148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060523000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2376060523000901"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2023.04.005","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatitis in a 57-Year-Old Female Two Weeks After Initiation of Empagliflozin","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2023.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}